CONNECT WITH US
AI & Deeptech

AI & Deeptech

Microsoft’s Medical AI Is Over Twice as Good Diagnosing Diseases as Doctors

Singularity Hub logo

Published on

Add as a preferred source on Google
Microsoft’s Medical AI Is Over Twice as Good Diagnosing Diseases as Doctors

The system, MAI-DxO, was not only more accurate, but it also spent much less on tests to make its diagnoses.

Doctors are like detectives. They scrutinize symptoms, piece together medical histories, and narrow down possible diagnoses. Simple cases may be solved on the spot. But trickier ones require tests to gradually zero in on the culprit.

The stakes are high. A misdiagnosis can delay treatment, allowing diseases to fester and cause lasting harm or prolonged suffering. Costs also stack up. Even with health insurance, multiple tests, some unnecessary in hindsight, can leave patients with staggering bills.

Medical debt is already a major burden in the US. According to one estimate, more than one-third of households carried some type of it in 2024. Some patients even opted out of subsequent care because of costs, which are often opaque.

A faster, more efficient path to the right diagnosis could vastly improve medical care. To that end, AI could be a useful tool. This month, in a paper published in Science, Microsoft researchers described MAI-DxO, a sophisticated system that acts like a crack medical team.

When challenged with extraordinarily complex cases, MAI-DxO was more than twice as accurate as physicians armed with textbooks and the internet—and nearly four times as accurate as those relying solely on their own knowledge. The system also surpassed doctors on typical emergency room cases, achieving 80 percent accuracy versus 47 percent for physicians.

“I’ve been working on principles and applications of AI in medicine since the 1980s,” study author Eric Horvitz told Science .


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.